Skip to main content
. 2019 Jun 11;10:1248. doi: 10.3389/fimmu.2019.01248

Figure 8.

Figure 8

CGD analysis. (A) Samples were analyzed by flow cytometry, gating on neutrophils by forward/side scatter and/or CD45/side scatter. (B) a healthy control, (C) Abnormal DHR expression in CGD patient, (D) X-linked carrier mother-mosaic pattern. NADPH oxidase component expression (7D5 for anti-gp91phox/p22phox, anti-p47phox, and anti-p67phox) was analyzed on neutrophils cells. (E) a healthy control, (F) Abnormal expression of gp91phox (CYBB gene) or p22phox (CYBA gene) in CGD patient, (G) X-linked carrier mother-mosaic pattern. (H) a healthy control, (I) Abnormal expression of p47phox (NCF1 gene) in CGD patient, (J) a healthy control, (K) Abnormal expression of p67phox (NCF2 gene) in CGD patient.